2017年4月10日星期一

Caspofungin


Caspofungin (INN) (brand name Cancidas worldwide) is a lipopeptide antifungal drug from Merck & Co., Inc. discovered by James Balkovec, Regina Black and Frances A. Bouffard. It is a member of a new class of antifungals termed the echinocandins. It works by inhibiting the enzyme (1→3)-β-D-glucan synthase and thereby disturbing the integrity of the fungal cell wall. Caspofungin was the first inhibitor of fungal (1→3)-β-D-glucan synthesis to be approved by the United States Food and Drug Administration. Caspofungin is administered intravenously.
Specification

ItemSpecifications    Result
AppearanceWhite or almost white powderOff white powder
Indentification

HPLC:The retention time of principle peak obtained from 
Test solution should conform with that obtained from 
Standard solution, as test in Assay
Conforms

IR: Spectrum of Test sample should conform to that 
of Caspofungin Acetate Reference Standard
Conforms
Specific Optical Rotation-102.0°~108.0 °-105.3°
PH5.0~7.06.5
Water10.0%7.5%
Solution color and claritySolution should be clear colorlessConforms
Related substances IImpurity A:  NMT 0.10%ND

Impurity B:  NMT 0.10%ND

Impurity D:  NMT 0.30%0.17%

Impurity E:  NMT 0.10%ND

Unspecified impurity F:  NMT 0.10%0.03%

Unspecified impurity G:  NMT 0.10%ND

Pneumocandin B0: NMT 0.10%ND

Each of unspecified impurity : NMT 0.10%0.04%

Total impurity:  NMT 1.0%0.24%
Related substances IIImpurity C: NMT 0.10%0.03%
Acetic acid9.0%~11.0%(calculated on anhydrous basis)10.1%
Heavy Metal as PbNMT 10ppmConforms

my contact infomation is:

Whatsapp: 008615032102186

Email: bettyapi1989@163.com 


Notice: This product is only suitable for laboratory use, or the use of animals. It can not be used directly on the human body

没有评论:

发表评论